No Discovery In Regeneron FCA Case Until 1st Circ. Rules
By Chris Villani · December 20, 2023, 5:59 PM EST
A False Claims Act case against Regeneron Pharmaceuticals Inc. will freeze completely while the government and the company argue the appeal of a crucial legal question, the presiding judge said Wednesday....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login